FLGT
Fulgent Genetics, Inc.
Price Chart
Latest Quote
$17.84
-0.16 (-0.89%)
Current Price
| Previous Close | $18.00 |
| Open | $18.01 |
| Day High | $18.30 |
| Day Low | $17.76 |
| Volume | 334,943 |
Stock Information
| Shares Outstanding | 28.40M |
| Total Debt | $10.17M |
| Cash Equivalents | $276.30M |
| Revenue | $320.35M |
| Net Income | $-73.81M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $506.67M |
| EPS (TTM) | $-2.40 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $234.88M |
| Sales | $320.35M |
| Income | $-73.81M |
| Book/sh | $36.39 |
| Cash/sh | $9.73 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 3.91 |
| Current Ratio | 5.32 |
| Debt/Eq | 0.97 |
Returns & Margins
| ROA | -5.37% |
| ROE | -6.92% |
| Gross Margin | 38.71% |
| Operating Margin | -45.01% |
| Profit Margin | -23.04% |
Ownership
| Insider Ownership | 36.66% |
| Institutional Ownership | 63.35% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -11.68 |
| P/S | 1.58 |
| P/B | 0.49 |
Analyst Data
| Recommendation | none |
| Target Price | $18.50 |
Technical Indicators
| SMA20 | $18.29 |
| SMA50 | $16.74 |
| SMA200 | $21.69 |
| RSI | 47.93 |
| ATR | 0.7871 |
| Shares Float | 17.56M |
| Short Float | 15.53% |
| Short Ratio | 4.48 |
| Volatility | 0.92 |
| Rel Volume | 0.76 |
Performance History
| Week | -4.50% |
| Month | +8.71% |
| Quarter | +15.02% |
| 6 Months | -35.13% |
| YTD | -30.29% |
| Year | -12.12% |
| 3 Years | -52.44% |
| 5 Years | -76.08% |
| 10 Years | +94.34% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $17.84 | 348,100 |
| 2026-06-18 | $18.00 | 684,400 |
| 2026-06-17 | $17.70 | 274,700 |
| 2026-06-16 | $17.99 | 228,100 |
| 2026-06-15 | $18.35 | 197,600 |
| 2026-06-12 | $18.68 | 218,800 |
| 2026-06-11 | $18.78 | 258,300 |
| 2026-06-10 | $18.93 | 327,600 |
| 2026-06-09 | $18.50 | 309,500 |
| 2026-06-08 | $18.31 | 334,000 |
| 2026-06-05 | $19.15 | 375,000 |
| 2026-06-04 | $19.50 | 603,200 |
| 2026-06-03 | $18.14 | 708,500 |
| 2026-06-02 | $18.70 | 738,200 |
| 2026-06-01 | $18.09 | 514,200 |
| 2026-05-29 | $18.14 | 1,185,300 |
| 2026-05-28 | $18.24 | 478,200 |
| 2026-05-27 | $17.90 | 416,300 |
| 2026-05-26 | $17.67 | 622,400 |
About Fulgent Genetics, Inc.
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
đ° Latest News
How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments
Simply Wall St. âĸ 2026-06-07T14:13:29Z
Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...
GuruFocus.com âĸ 2026-05-02T07:01:31ZFulgent Genetics, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-01T20:46:27Z
Fulgent Genetics Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-01T13:52:12Z
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-01T12:10:02Z
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-04-30T22:25:11Z
Fulgent Genetics (FLGT) Is Down 33.4% After 2025 Results And Oncology-Focused Expansion - What's Changed
Simply Wall St. âĸ 2026-03-02T21:08:09Z
A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue Guidance
Simply Wall St. âĸ 2026-03-01T15:09:25Z
Fulgent Genetics, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-28T13:30:00Z
Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
GuruFocus.com âĸ 2026-02-27T21:05:13Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $175,704,000 | $159,292,000 | $166,459,000 | $225,902,000 |
| Cost Of Revenue | $191,796,000 | $176,255,000 | $184,757,000 | $252,067,000 |
| Total Revenue | $322,671,000 | $283,470,000 | $289,213,000 | $618,968,000 |
| Operating Revenue | $322,671,000 | $283,470,000 | $289,213,000 | $618,968,000 |
| Expenses | ||||
| Interest Expense | $75,000 | - | $488,000 | $1,013,000 |
| Total Expenses | $413,767,000 | $357,388,000 | $364,508,000 | $437,466,000 |
| Other Income Expense | $-9,773,000 | $-9,512,000 | $-119,914,000 | $-2,088,000 |
| Other Non Operating Income Expenses | $153,000 | $561,000 | $320,000 | $887,000 |
| Net Non Operating Interest Income Expense | $30,844,000 | $31,474,000 | $21,124,000 | $4,611,000 |
| Interest Expense Non Operating | $75,000 | - | $488,000 | $1,013,000 |
| Operating Expense | $221,971,000 | $181,133,000 | $179,751,000 | $185,399,000 |
| Selling And Marketing Expense | $43,371,000 | $36,246,000 | $41,467,000 | $38,918,000 |
| General And Administrative Expense | $116,664,000 | $88,106,000 | $88,999,000 | $111,074,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-60,513,000 | $-42,708,000 | $-167,825,000 | $143,403,000 |
| Net Interest Income | $30,844,000 | $31,474,000 | $21,124,000 | $4,611,000 |
| Interest Income | $30,919,000 | $31,474,000 | $21,612,000 | $5,624,000 |
| Normalized Income | $-51,777,127 | $-34,257,760 | $-72,840,140 | $145,702,675 |
| Net Income From Continuing And Discontinued Operation | $-60,513,000 | $-42,708,000 | $-167,825,000 | $143,403,000 |
| Total Operating Income As Reported | $-91,096,000 | $-73,918,000 | $-195,529,000 | $178,527,000 |
| Net Income Common Stockholders | $-60,513,000 | $-42,708,000 | $-167,825,000 | $143,403,000 |
| Net Income | $-60,513,000 | $-42,708,000 | $-167,825,000 | $143,403,000 |
| Net Income Including Noncontrolling Interests | $-61,631,000 | $-43,820,000 | $-175,239,000 | $141,923,000 |
| Net Income Continuous Operations | $-61,631,000 | $-43,820,000 | $-175,239,000 | $141,923,000 |
| Pretax Income | $-70,025,000 | $-51,956,000 | $-174,085,000 | $184,025,000 |
| Special Income Charges | $-9,926,000 | $-10,073,000 | $-120,234,000 | $-2,975,000 |
| Interest Income Non Operating | $30,919,000 | $31,474,000 | $21,612,000 | $5,624,000 |
| Operating Income | $-91,096,000 | $-73,918,000 | $-75,295,000 | $181,502,000 |
| Depreciation Amortization Depletion Income Statement | $8,031,000 | $7,965,000 | $7,845,000 | $6,497,000 |
| Depreciation And Amortization In Income Statement | $8,031,000 | $7,965,000 | $7,845,000 | $6,497,000 |
| Amortization Of Intangibles Income Statement | $8,031,000 | $7,965,000 | $7,845,000 | $6,497,000 |
| Gross Profit | $130,875,000 | $107,215,000 | $104,456,000 | $366,901,000 |
| Earnings From Equity Interest Net Of Tax | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $-1.97 | $-1.41 | $-5.63 | $4.63 |
| Basic EPS | $-1.97 | $-1.41 | $-5.63 | $4.76 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,190,127 | $-1,622,760 | $-25,249,140 | $-675,325 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-35,901,000 | $-38,917,000 | $-27,220,000 | $220,675,000 |
| Total Unusual Items | $-9,926,000 | $-10,073,000 | $-120,234,000 | $-2,975,000 |
| Total Unusual Items Excluding Goodwill | $-9,926,000 | $-10,073,000 | $-120,234,000 | $-2,975,000 |
| Reconciled Depreciation | $24,123,000 | $24,928,000 | $26,143,000 | $32,662,000 |
| EBITDA (Bullshit earnings) | $-45,827,000 | $-48,990,000 | $-147,454,000 | $217,700,000 |
| EBIT | $-69,950,000 | $-73,918,000 | $-173,597,000 | $185,038,000 |
| Diluted Average Shares | $30,777,000 | $30,235,000 | $29,784,000 | $30,964,000 |
| Basic Average Shares | $30,777,000 | $30,235,000 | $29,784,000 | $30,097,000 |
| Diluted NI Availto Com Stockholders | $-60,513,000 | $-42,708,000 | $-167,825,000 | $143,403,000 |
| Minority Interests | $1,118,000 | $1,112,000 | $7,414,000 | $1,480,000 |
| Tax Provision | $-8,394,000 | $-8,136,000 | $1,154,000 | $42,102,000 |
| Write Off | $9,926,000 | $10,073,000 | $0 | $0 |
| Impairment Of Capital Assets | $0 | $0 | $120,234,000 | $0 |
| Amortization | $8,031,000 | $7,965,000 | $7,845,000 | $6,497,000 |
| Research And Development | $53,905,000 | $48,816,000 | $41,440,000 | $28,910,000 |
| Selling General And Administration | $160,035,000 | $124,352,000 | $130,466,000 | $149,992,000 |
| Other Gand A | $116,664,000 | $88,106,000 | $88,999,000 | $111,074,000 |
| Restructuring And Mergern Acquisition | - | $0 | $0 | $2,975,000 |
| Salaries And Wages | - | - | - | - |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $953,628,000 | $976,195,000 | $970,993,000 | $973,015,000 |
| Total Assets | $1,213,525,000 | $1,219,964,000 | $1,235,328,000 | $1,386,053,000 |
| Total Non Current Assets | $663,035,000 | $866,393,000 | $727,483,000 | $758,180,000 |
| Other Non Current Assets | $22,856,000 | $33,460,000 | $34,902,000 | $44,124,000 |
| Investmentin Financial Assets | $369,269,000 | $570,351,000 | $444,009,000 | $339,033,000 |
| Goodwill And Other Intangible Assets | $158,361,000 | $157,033,000 | $165,108,000 | $293,670,000 |
| Other Intangible Assets | $133,281,000 | $134,978,000 | $143,053,000 | $150,643,000 |
| Current Assets | $550,490,000 | $353,571,000 | $507,845,000 | $627,873,000 |
| Prepaid Assets | $112,199,000 | $10,051,000 | $20,419,000 | $22,248,000 |
| Inventory | $10,604,000 | $8,384,000 | $5,827,000 | $4,280,000 |
| Receivables | $91,610,000 | $77,030,000 | $57,445,000 | $75,110,000 |
| Other Receivables | $1,134,000 | $1,768,000 | $1,319,000 | $19,836,000 |
| Accrued Interest Receivable | $5,714,000 | $6,241,000 | $4,994,000 | $2,525,000 |
| Accounts Receivable | $84,762,000 | $69,021,000 | $51,132,000 | $52,749,000 |
| Allowance For Doubtful Accounts Receivable | $-21,411,000 | $-20,458,000 | $-25,226,000 | $-41,205,000 |
| Gross Accounts Receivable | $106,173,000 | $89,479,000 | $76,358,000 | $93,954,000 |
| Cash Cash Equivalents And Short Term Investments | $336,077,000 | $258,106,000 | $424,154,000 | $526,235,000 |
| Cash And Cash Equivalents | $50,193,000 | $55,144,000 | $97,473,000 | $79,506,000 |
| Debt | ||||
| Total Debt | $7,677,000 | $8,468,000 | $15,251,000 | $38,937,000 |
| Long Term Debt And Capital Lease Obligation | $5,739,000 | $6,613,000 | $10,111,000 | $12,167,000 |
| Long Term Debt | $1,958,000 | $2,493,000 | $2,964,000 | $3,372,000 |
| Current Debt And Capital Lease Obligation | $1,938,000 | $1,855,000 | $5,140,000 | $26,770,000 |
| Current Debt | $476,000 | $412,000 | $1,183,000 | $20,638,000 |
| Other Current Borrowings | $476,000 | $412,000 | $1,183,000 | $20,638,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $106,810,000 | $90,805,000 | $102,042,000 | $116,178,000 |
| Total Non Current Liabilities Net Minority Interest | $21,843,000 | $17,906,000 | $29,024,000 | $28,071,000 |
| Other Non Current Liabilities | $9,168,000 | $4,923,000 | $10,951,000 | $15,904,000 |
| Non Current Deferred Liabilities | $6,936,000 | $6,370,000 | $7,962,000 | $0 |
| Non Current Deferred Taxes Liabilities | $6,936,000 | $6,370,000 | $7,962,000 | $0 |
| Current Liabilities | $84,967,000 | $72,899,000 | $73,018,000 | $88,107,000 |
| Current Deferred Liabilities | $31,780,000 | $29,844,000 | $25,574,000 | $14,094,000 |
| Payables And Accrued Expenses | $40,789,000 | $31,309,000 | $35,885,000 | $41,942,000 |
| Payables | $18,654,000 | $18,364,000 | $15,360,000 | $23,093,000 |
| Accounts Payable | $18,654,000 | $18,364,000 | $15,360,000 | $23,093,000 |
| Other Current Liabilities | - | - | $164,000 | $5,301,000 |
| Current Notes Payable | - | - | - | $5,639,000 |
| Total Tax Payable | - | - | - | $0 |
| Income Tax Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $1,111,989,000 | $1,133,228,000 | $1,136,101,000 | $1,266,685,000 |
| Total Equity Gross Minority Interest | $1,106,715,000 | $1,129,159,000 | $1,133,286,000 | $1,269,875,000 |
| Stockholders Equity | $1,111,989,000 | $1,133,228,000 | $1,136,101,000 | $1,266,685,000 |
| Gains Losses Not Affecting Retained Earnings | $7,512,000 | $-368,000 | $1,205,000 | $-20,903,000 |
| Other Equity Adjustments | $7,512,000 | $-368,000 | $1,205,000 | $-20,903,000 |
| Retained Earnings | $529,954,000 | $590,467,000 | $633,175,000 | $801,000,000 |
| Other | ||||
| Treasury Shares Number | $3,420,000 | $2,773,000 | $2,763,000 | - |
| Ordinary Shares Number | $31,081,000 | $30,841,000 | $29,653,000 | $29,438,000 |
| Share Issued | $34,501,000 | $33,614,000 | $32,416,000 | $29,438,000 |
| Tangible Book Value | $953,628,000 | $976,195,000 | $970,993,000 | $973,015,000 |
| Invested Capital | $1,114,423,000 | $1,136,133,000 | $1,140,248,000 | $1,290,695,000 |
| Working Capital | $465,523,000 | $280,672,000 | $434,827,000 | $539,766,000 |
| Capital Lease Obligations | $5,243,000 | $5,563,000 | $11,104,000 | $14,927,000 |
| Total Capitalization | $1,113,947,000 | $1,135,721,000 | $1,139,065,000 | $1,270,057,000 |
| Minority Interest | $-5,274,000 | $-4,069,000 | $-2,815,000 | $3,190,000 |
| Additional Paid In Capital | $574,520,000 | $543,126,000 | $501,718,000 | $486,585,000 |
| Capital Stock | $3,000 | $3,000 | $3,000 | $3,000 |
| Common Stock | $3,000 | $3,000 | $3,000 | $3,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $3,781,000 | $4,120,000 | $7,147,000 | $8,795,000 |
| Current Deferred Revenue | $31,780,000 | $29,844,000 | $25,574,000 | $14,094,000 |
| Current Capital Lease Obligation | $1,462,000 | $1,443,000 | $3,957,000 | $6,132,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $10,460,000 | $9,891,000 | $6,255,000 | - |
| Current Accrued Expenses | $22,135,000 | $12,945,000 | $20,525,000 | $18,849,000 |
| Investments And Advances | $369,269,000 | $570,351,000 | $444,009,000 | $339,033,000 |
| Available For Sale Securities | $369,269,000 | $570,351,000 | $444,009,000 | $339,033,000 |
| Goodwill | $25,080,000 | $22,055,000 | $22,055,000 | $143,027,000 |
| Net PPE | $112,549,000 | $105,549,000 | $83,464,000 | $81,353,000 |
| Accumulated Depreciation | $-57,945,000 | $-51,711,000 | $-51,633,000 | $-43,281,000 |
| Gross PPE | $170,494,000 | $157,260,000 | $135,097,000 | $124,634,000 |
| Leases | $4,473,000 | $3,323,000 | $11,222,000 | $11,804,000 |
| Other Properties | $66,753,000 | $60,441,000 | $71,150,000 | $66,424,000 |
| Machinery Furniture Equipment | $26,096,000 | $25,632,000 | $25,492,000 | $25,406,000 |
| Buildings And Improvements | $54,887,000 | $49,613,000 | $17,529,000 | $12,596,000 |
| Land And Improvements | $18,285,000 | $18,251,000 | $9,704,000 | $8,404,000 |
| Properties | $0 | $0 | $0 | $0 |
| Raw Materials | $10,604,000 | $8,384,000 | $5,827,000 | $4,280,000 |
| Other Short Term Investments | $285,884,000 | $202,962,000 | $326,681,000 | $446,729,000 |
| Other Investments | - | - | - | $12,385,000 |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-124,212,000 | $-19,255,000 | $4,796,000 | $234,745,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-101,638,000 | $21,060,000 | $27,003,000 | $253,520,000 |
| Cash Flow From Continuing Operating Activities | $-101,638,000 | $21,060,000 | $27,003,000 | $253,520,000 |
| Operating Gains Losses | $-65,000 | $1,314,000 | $894,000 | $1,194,000 |
| Investing Activities | ||||
| Capital Expenditure | $-22,574,000 | $-40,315,000 | $-22,207,000 | $-18,775,000 |
| Investing Cash Flow | $111,371,000 | $-58,352,000 | $38,898,000 | $-261,314,000 |
| Cash Flow From Continuing Investing Activities | $111,371,000 | $-58,352,000 | $38,898,000 | $-261,314,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-13,920,000 | $-3,124,000 | $-27,792,000 | $-76,105,000 |
| Financing Cash Flow | $-14,789,000 | $-4,847,000 | $-47,785,000 | $-77,141,000 |
| Cash Flow From Continuing Financing Activities | $-14,789,000 | $-4,847,000 | $-47,785,000 | $-77,141,000 |
| Net Common Stock Issuance | $-13,920,000 | $-3,124,000 | $-27,792,000 | $-76,105,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Net Other Financing Charges | - | - | $-15,000,000 | $-1,768,000 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-870,000 | $-1,774,000 | $-19,996,000 | $-1,067,000 |
| Interest Paid Supplemental Data | $52,000 | $512,000 | $960,000 | $0 |
| Income Tax Paid Supplemental Data | $96,445,000 | $27,588,000 | $3,261,000 | $56,193,000 |
| End Cash Position | $50,328,000 | $55,279,000 | $97,473,000 | $79,506,000 |
| Beginning Cash Position | $55,279,000 | $97,473,000 | $79,506,000 | $164,894,000 |
| Effect Of Exchange Rate Changes | $105,000 | $-55,000 | $-149,000 | $-453,000 |
| Changes In Cash | $-5,056,000 | $-42,139,000 | $18,116,000 | $-84,935,000 |
| Proceeds From Stock Option Exercised | $1,000 | $51,000 | $3,000 | $31,000 |
| Common Stock Payments | $-13,920,000 | $-3,124,000 | $-27,792,000 | $-76,105,000 |
| Net Issuance Payments Of Debt | $-870,000 | $-1,774,000 | $-19,996,000 | $-1,067,000 |
| Net Short Term Debt Issuance | $-471,000 | $-1,230,000 | $-19,266,000 | $-367,000 |
| Short Term Debt Payments | $-471,000 | $-1,230,000 | $-19,266,000 | $-367,000 |
| Net Long Term Debt Issuance | $-399,000 | $-544,000 | $-730,000 | $-700,000 |
| Long Term Debt Payments | $-399,000 | $-544,000 | $-730,000 | $-700,000 |
| Net Investment Purchase And Sale | $130,165,000 | $-18,350,000 | $60,729,000 | $-60,272,000 |
| Sale Of Investment | $211,007,000 | $454,065,000 | $552,643,000 | $372,710,000 |
| Purchase Of Investment | $-80,842,000 | $-472,415,000 | $-491,914,000 | $-432,982,000 |
| Net Business Purchase And Sale | $3,775,000 | $0 | $-399,000 | $-182,679,000 |
| Sale Of Business | $3,775,000 | - | - | - |
| Net PPE Purchase And Sale | $-22,569,000 | $-40,002,000 | $-21,432,000 | $-18,363,000 |
| Sale Of PPE | $5,000 | $313,000 | $775,000 | $412,000 |
| Purchase Of PPE | $-22,574,000 | $-40,315,000 | $-22,207,000 | $-18,775,000 |
| Change In Working Capital | $-117,634,000 | $-7,239,000 | $2,841,000 | $2,005,000 |
| Change In Other Working Capital | $-103,017,000 | $13,531,000 | $14,249,000 | $-34,928,000 |
| Change In Other Current Liabilities | $-1,625,000 | $-3,771,000 | $-6,287,000 | $-4,831,000 |
| Change In Other Current Assets | $798,000 | $199,000 | $-3,331,000 | $9,380,000 |
| Change In Payables And Accrued Expense | $9,461,000 | $-895,000 | $-4,178,000 | $-36,254,000 |
| Change In Accrued Expense | $8,911,000 | $-3,961,000 | $2,718,000 | $-10,915,000 |
| Change In Payable | $550,000 | $3,066,000 | $-6,896,000 | $-25,339,000 |
| Change In Account Payable | $550,000 | $3,066,000 | $-6,896,000 | $-25,339,000 |
| Change In Receivables | $-23,251,000 | $-16,303,000 | $2,388,000 | $68,638,000 |
| Changes In Account Receivables | $-23,251,000 | $-16,303,000 | $2,388,000 | $68,638,000 |
| Other Non Cash Items | $1,794,000 | $3,753,000 | $6,391,000 | $4,902,000 |
| Stock Based Compensation | $39,582,000 | $44,481,000 | $42,922,000 | $32,640,000 |
| Provisionand Write Offof Assets | $7,648,000 | $-1,730,000 | $-880,000 | $32,596,000 |
| Asset Impairment Charge | $9,926,000 | $10,073,000 | $120,234,000 | $0 |
| Amortization Of Securities | $-5,103,000 | $-5,550,000 | $-3,911,000 | $4,767,000 |
| Deferred Tax | $-278,000 | $-5,150,000 | $7,608,000 | $831,000 |
| Deferred Income Tax | $-278,000 | $-5,150,000 | $7,608,000 | $831,000 |
| Depreciation Amortization Depletion | $24,123,000 | $24,928,000 | $26,143,000 | $32,662,000 |
| Depreciation And Amortization | $24,123,000 | $24,928,000 | $26,143,000 | $32,662,000 |
| Gain Loss On Investment Securities | $-62,000 | $994,000 | $589,000 | $692,000 |
| Gain Loss On Sale Of PPE | $-3,000 | $320,000 | $305,000 | $502,000 |
| Net Income From Continuing Operations | $-61,631,000 | $-43,820,000 | $-175,239,000 | $141,923,000 |
| Purchase Of Business | - | $0 | $-399,000 | $-182,679,000 |
| Net Intangibles Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Intangibles | - | - | $0 | $0 |
| Change In Tax Payable | - | - | $0 | $-827,000 |
| Change In Income Tax Payable | - | - | $0 | $-827,000 |
| Gain Loss On Sale Of Business | - | - | $0 | $0 |
| Issuance Of Debt | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Earnings Losses From Equity Investments | - | - | - | $0 |
Fetched: 2026-06-21